Cargando…
Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries
BACKGROUND: Tuberculosis (TB) control is considered primarily a public health concern, and private sector TB treatment has attracted less attention. Thus, the size and characteristics of private sector TB drug sales remain largely unknown. METHODOLOGY/PRINCIPAL FINDINGS: We used IMS Health data to a...
Autores principales: | Wells, William A., Ge, Colin Fan, Patel, Nitin, Oh, Teresa, Gardiner, Elizabeth, Kimerling, Michael E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087727/ https://www.ncbi.nlm.nih.gov/pubmed/21573227 http://dx.doi.org/10.1371/journal.pone.0018964 |
Ejemplares similares
-
One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries
por: Klinton, Joel Shyam, et al.
Publicado: (2021) -
Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines
por: Coghlan, Renia, et al.
Publicado: (2015) -
Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?
por: Adepoju, Victor Abiola, et al.
Publicado: (2022) -
Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
por: Jarde, Alexander, et al.
Publicado: (2022) -
Correction: Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
por: Jarde, Alexander, et al.
Publicado: (2023)